Bachmann D, Wybitul M, Buchmann A, Gericke C, et al. Predicting cognitive decline with amyloid-PET, plasma p-tau217, Abeta42/40, and p-tau217/Abeta42 in a community-based cohort - relevance for clinical trial enrollment. Alzheimers Dement 2025;21:e70802.
PMID: 41117398